Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.93 USD
Change Today -0.06 / -0.50%
Volume 780.0K
VNDA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - vanda pharmaceuticals inc (VNDA)

NameBoard RelationshipsTitleAge
Mihael H. Polymeropoulos M.D.5 RelationshipsFounder, Chief Executive Officer, President and Director55
James Patrick Kelly No RelationshipsChief Financial Officer, Senior Vice President, Treasurer and Secretary49
Paolo Baroldi M.D., Ph.D.No RelationshipsChief Medical Officer and Senior Vice President64
Thomas E. Gibbs No RelationshipsChief Commercial Officer and Senior Vice President43
Louis Licamele Ph.D.No RelationshipsHead of Informatics and Senior Director--

Board Members - vanda pharmaceuticals inc (VNDA)

NameBoard RelationshipsPrimary CompanyAge
H. Thomas Watkins 123 RelationshipsVanda Pharmaceuticals, Inc.62
Mihael H. Polymeropoulos M.D.5 RelationshipsVanda Pharmaceuticals, Inc.55
Richard W. Dugan 12 RelationshipsVanda Pharmaceuticals, Inc.73
Vincent J. Milano 167 RelationshipsIdera Pharmaceuticals, Inc.51
Howard H. Pien 55 RelationshipsJuno Therapeutics Inc.57

Executive Committees* - vanda pharmaceuticals inc (VNDA)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeRichard W. Dugan 12 Relationships3 Executives
Compensation CommitteeVincent J. Milano 167 Relationships3 Executives
Nominating CommitteeH. Thomas Watkins 123 Relationships3 Executives
Corporate Governance CommitteeH. Thomas Watkins 123 Relationships3 Executives
View VNDA Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $11.93 USD -0.06

VNDA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,120 GBp +36.00
Bristol-Myers Squibb Co $60.61 USD -0.21
Eli Lilly & Co $83.19 USD -0.55
Pernix Therapeutics Holdings Inc $4.70 USD +0.10
Sanofi €88.44 EUR -0.12
View Industry Companies
 

Industry Analysis

VNDA

Industry Average

Valuation VNDA Industry Range
Price/Earnings 9.2x
Price/Sales 6.3x
Price/Book 3.4x
Price/Cash Flow 8.3x
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.